{"@context":"https://schema.org","@graph":[{"@type":"MedicalScholarlyArticle","@id":"https://synapsesocial.com/papers/6ab9ec4c4dd1e24f84751d42#article","headline":"Cytokines and adhesion molecules in renal vasculitis and lupus nephritis","name":"Cytokines and adhesion molecules in renal vasculitis and lupus nephritis","url":"https://synapsesocial.com/papers/6ab9ec4c4dd1e24f84751d42","inLanguage":"en","datePublished":"Wed, 01 Jul 1998 00:00:00 GMT","dateCreated":"Fri, 10 Oct 2025 00:00:00 GMT","abstract":"BACKGROUND: Plasma levels of some pro-inflammatory cytokines and soluble adhesion molecules have been suggested to be useful parameters to assess the activity of antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis and lupus nephritis. We hypothesized that the renal activity of these diseases is better reflected by the urinary excretion and fractional excretion of these molecules. METHODS: Plasma levels and urinary excretion of tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, IL-8, and the soluble cell adhesion molecules sICAM-1 and sVCAM-1 were measured by enzyme-linked immunosorbent assay (ELISA) in 14 patients with ANCA-positive renal vasculitis (eight active, ANCA-A; six in remission, ANCA-R), six patients with active lupus nephritis (LN), 15 patients with IgA nephropathy (IgAN) and nine healthy subjects. Fractional excretion of selected cytokines and adhesion molecules was also calculated. RESULTS: Patients with ANCA-A had increased urinary excretion and fractional excretion of TNF-alpha (9.27 +/- 3.19% vs 0.58 +/- 0.02%, P < 0.01), IL-6 (120.79 +/- 65.83% vs 1.89 +/- 0.34%, P < 0.01) and increased fractional excretion of IL-8 (23.34 +/- 6.38% vs 2.56 +/- 1.07%, P < 0.01) and sVCAM-1 (0.81 +/- 0.33% vs 0.03 +/- 0.02%, P < 0.01) compared with controls. Urinary excretion of TNF-alpha and IL-6 and fractional excretion of TNFalpha, IL-6 and IL-8 were higher in ANCA-A than in ANCA-R. Patients with LN had increased plasma TNF-alpha (20.52 +/- 2.01 pg/ml vs 12.33 +/- 0.23 pg/ml, P < 0.05) and sVCAM-1 (1537.88 +/- 276.36 ng/ml vs 692.26 +/- 44.42 ng/ml, P < 0.05) and increased urinary excretion of TNF-alpha (2.81 +/- 0.51 microg/mol creat vs 0.98 +/- 0.05 microg/mol creat, P < 0.01), IL-8 (35.78 +/- 14.03 microg/mol creat vs 12.46 +/- 5.19 microg/mol creat, P < 0.05) and sVCAM-1 (48.98 +/- 20.20 microg/mol creat vs 2.92 +/- 1.35 microg/mol creat, P < 0.01) compared with controls. Patients with IgAN had, in comparison with controls only increased plasma TNF-alpha (18.10 +/- 0.57 pg/ml vs 12.33 +/- 0.23 pg/ml, P < 0.05). CONCLUSIONS: Urinary excretion and fractional excretion, but not plasma levels, of selected pro-inflammatory cytokines (TNF-alpha, IL-6 and IL-8) were increased in patients with active ANCA-positive renal vasculitis, but not in ANCA positive vasculitis in remission. These parameters may be useful to monitor the activity of this disease.","description":"BACKGROUND: Plasma levels of some pro-inflammatory cytokines and soluble adhesion molecules have been suggested to be useful parameters to assess the activity of antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis and lupus nephritis. We hypothesized that the renal activity of these diseases is better reflected by the urinary excretion and fractional excretion of these molecules. METHODS: Plasma levels and urinary excretion of tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-6, IL-8, and the soluble cell adhesion molecules sICAM-1 and sVCAM-1 were measured by enzyme-linked immunosorbent assay (ELISA) in 14 patients with ANCA-positive renal vasculitis (eight active, ANCA-A; six in remission, ANCA-R), six patients with active lupus nephritis (LN), 15 patients with IgA nephropathy (IgAN) and nine healthy subjects. Fractional excretion of selected cytokines and adhesion molecules was also calculated. RESULTS: Patients with ANCA-A had increased urinary excretion and fractional excretion of TNF-alpha (9.27 +/- 3.19% vs 0.58 +/- 0.02%, P < 0.01), IL-6 (120.79 +/- 65.83% vs 1.89 +/- 0.34%, P < 0.01) and increased fractional excretion of IL-8 (23.34 +/- 6.38% vs 2.56 +/- 1.07%, P < 0.01) and sVCAM-1 (0.81 +/- 0.33% vs 0.03 +/- 0.02%, P < 0.01) compared with controls. Urinary excretion of TNF-alpha and IL-6 and fractional excretion of TNFalpha, IL-6 and IL-8 were higher in ANCA-A than in ANCA-R. Patients with LN had increased plasma TNF-alpha (20.52 +/- 2.01 pg/ml vs 12.33 +/- 0.23 pg/ml, P < 0.05) and sVCAM-1 (1537.88 +/- 276.36 ng/ml vs 692.26 +/- 44.42 ng/ml, P < 0.05) and increased urinary excretion of TNF-alpha (2.81 +/- 0.51 microg/mol creat vs 0.98 +/- 0.05 microg/mol creat, P < 0.01), IL-8 (35.78 +/- 14.03 microg/mol creat vs 12.46 +/- 5.19 microg/mol creat, P < 0.05) and sVCAM-1 (48.98 +/- 20.20 microg/mol creat vs 2.92 +/- 1.35 microg/mol creat, P < 0.01) compared with controls. Patients with IgAN had, in comparison with controls only increased plasma TNF-alpha (18.10 +/- 0.57 pg/ml vs 12.33 +/- 0.23 pg/ml, P < 0.05). CONCLUSIONS: Urinary excretion and fractional excretion, but not plasma levels, of selected pro-inflammatory cytokines (TNF-alpha, IL-6 and IL-8) were increased in patients with active ANCA-positive renal vasculitis, but not in ANCA positive vasculitis in remission. These parameters may be useful to monitor the activity of this disease.","author":[{"@type":"Person","name":"Vladimı́r Tesař","url":"https://synapsesocial.com/authors/A5081888215"}],"isPartOf":{"@type":"Periodical","name":"Nephrology Dialysis Transplantation","url":"https://synapsesocial.com/journals/6896392538e66137c43530d3"},"publisher":{"@type":"Periodical","name":"Nephrology Dialysis Transplantation","url":"https://synapsesocial.com/journals/6896392538e66137c43530d3"},"sourceOrganization":[{"@type":"Organization","name":"Charles University","url":"https://synapsesocial.com/institutions/68924f578807423d81a6dd5b"}],"isBasedOn":"https://doi.org/10.1093/ndt/13.7.1662","identifier":[{"@type":"PropertyValue","propertyID":"DOI","value":"10.1093/ndt/13.7.1662"},{"@type":"PropertyValue","propertyID":"OpenAlex","value":"https://openalex.org/W2163068834"}],"sameAs":["https://doi.org/10.1093/ndt/13.7.1662","https://openalex.org/https://openalex.org/W2163068834"],"citationCount":76},{"@type":"MedicalWebPage","@id":"https://synapsesocial.com/papers/6ab9ec4c4dd1e24f84751d42#webpage","url":"https://synapsesocial.com/papers/6ab9ec4c4dd1e24f84751d42","name":"Cytokines and adhesion molecules in renal vasculitis and lupus nephritis","about":{"@id":"https://synapsesocial.com/papers/6ab9ec4c4dd1e24f84751d42#article"},"mainContentOfPage":{"@id":"https://synapsesocial.com/papers/6ab9ec4c4dd1e24f84751d42#article"},"medicalAudience":[{"@type":"MedicalAudience","audienceType":"Clinician"},{"@type":"MedicalAudience","audienceType":"Researcher"}],"inLanguage":"en","isPartOf":{"@type":"WebSite","@id":"https://synapsesocial.com#website","url":"https://synapsesocial.com","name":"Synapse"},"lastReviewed":"Fri, 10 Oct 2025 00:00:00 GMT"},{"@type":"BreadcrumbList","@id":"https://synapsesocial.com/papers/6ab9ec4c4dd1e24f84751d42#breadcrumbs","itemListElement":[{"@type":"ListItem","position":1,"name":"Synapse","item":"https://synapsesocial.com"},{"@type":"ListItem","position":2,"name":"Explore","item":"https://synapsesocial.com/explore"},{"@type":"ListItem","position":3,"name":"Cytokines and adhesion molecules in renal vasculitis and lupus nephritis","item":"https://synapsesocial.com/papers/6ab9ec4c4dd1e24f84751d42"}]}]}

Cytokines and adhesion molecules in renal vasculitis and lupus nephritis

Discussion

Member takes

Implication

Key Points

Cite This Study

Cytokines and adhesion molecules in renal vasculitis and lupus nephritis

Discussion

Member takes

Implication

Key Points

Cite This Study